May 11, 2020 / 12:00PM GMT
Operator
Greetings, and welcome to the Pieris Pharmaceuticals First Quarter 2020 Earnings Call. (Operator Instructions). As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Mr. Tom Bures, Vice President of Finance for Pieris Pharmaceuticals. Thank you. You may begin.
Thomas Bures - Pieris Pharmaceuticals, Inc. - VP of Finance
Good morning, everyone, and thank you for joining us for our first quarter 2020 conference call and corporate update. On the call today, we have Steve Yoder, our President and CEO, who will provide a corporate overview and outlook on our pipeline; Hitto Kaufmann, our Chief Scientific Officer; Ingmar Bruns, our SVP and Head of Clinical Development; and Shane Olwill, our SVP and Head of Translational Science, who will be available for Q&A. You can access the press release released this morning on the Investor Relations page of our website at www.pieris.com.
Before we begin, I'd like to caution that comments made during this
Q1 2020 Pieris Pharmaceuticals Inc Earnings Call Transcript
May 11, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers